{"symbol": "BEAM", "companyName": "Beam Therapeutics Inc", "exchange": "NASDAQ", "industry": "Biological Product (except Diagnostic) Manufacturing ", "website": "beamtx.com", "description": "Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.", "CEO": "", "securityName": "Beam Therapeutics Inc", "issueType": "cs", "sector": "Manufacturing", "primarySicCode": 2836, "employees": 508, "tags": ["Health Technology", "Biotechnology", "Manufacturing", "Biological Product (except Diagnostic) Manufacturing "], "address": null, "address2": null, "state": null, "city": null, "zip": null, "country": null, "phone": null}